Directory Neurotropic funds Local anaesthetics Inocain
This page is translated automatically with a help of Google Translate

Inocain

See also Oxybuprocaine

Roman name

Inokain

The composition and the form of

Eye drops 0.4% in January mloksibuprokain 0.4% benzalconia chloride - 0.01% in the plastic vial with capelnica or vial dark glasses capelnica 5 ml per bundle cartons 1 a bottle.

Characteristics

Is TV paraaminobensana acid.

Clinical pharmacology

0.4% Inocaina solution widely used in ophthalmology, because after putting in the eye quickly produces superficial diseases is insignificant irritant effect on the haemorrhage has good penetration ability in the epithelium and little is having a damaging impact.

Indications

Measuring vnutriglaznogo pressure (tonometria); Gonioskopia; Diagnostic soskob kongyunctiv; Removal of foreign bodies and joints of the cornea and kongyunctiv; Short surgery the cornea and conjunctiva.

Contraindications

Hypersensitivity to any of the components of the preparation.

Side-Effects

Pokalawania feeling, pain and redness kongyunctiv; Rarely expressed allergic reaction to the development keratita.

Specific guidance

The drug is not recommended for the independent home application, as his long, repeated and prolonged use (as well as other local anesthetics) could lead to a stable pomutneniu Rogovitsy.ne designed for long-term therapy in the treatment of diseases Glaz.ne handle hair apparent to any surfaces, in order to avoid contamination of the preparation.

Patient interaction

Unknown.

Precautions

Apply for instillation in kongungualny bag. There used to Ingyektion.vo time anaesthesia, it is important to protect the eye from irritating chemical exposures, foreign bodies and friction. Patients should be forbidden to touch the eyes to the end of anaesthesia.

Storage conditions

In the dark place at a temperature below 25 ° C. (not freezing)

Shelf life

2

The registration

012272/01-2000

The drug forms

Transparent colourless solution.

All products of this group